Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 800 participants.
Also called NCT02094963
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 800 participants
- Registry
-
NCT02094963
-
- Other papers using this trial's data
- Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02094963. Randomized; no masking; primary purpose treatment. Start 2014-07-05 (actual); primary completion 2018-11-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
- Acronym
- TICA KOREA
- Condition
- Acute Coronary Syndrome
- Condition
- Myocardial Ischemia
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Angina Pectoris
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Seung-Jung Park
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct02094963- Content hash
6020320310b702486a54fee260b02a6d98424389abf72c3bbd3b22ca16571d4c